Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06800248 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

Study acronym: TREMO-Siargao
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 32 days later Apr 2027 → Jun 2027
See other at-risk trials from Swiss Tropical & Public Health Institute

Record History

  1. Start date: Sep 2026 to Nov 6, 2026 Primary completion pushed from Apr 2027 to Jun 2027 · Completion pushed from Aug 2027 to Oct 2027 · Eligibility criteria shortened, about 8 words · 1 morev7 Show 4 more changesShow less
    • Primary completion pushed from Apr 2027 to Jun 2027
    • Completion pushed from Aug 2027 to Oct 2027
    • Eligibility criteria shortened, about 8 words
    • Collaborators revised (3)

    See this version in full on ClinicalTrials.gov ↗

  2. Study site revisedv6 See this version in full on ClinicalTrials.gov ↗
  3. Primary completion pushed from Sep 2026 to Apr 2027 Start date: Apr 2026 to Sep 2026 · Completion pushed from Dec 2026 to Aug 2027v5 Show 2 more changesShow less
    • Start date: Apr 2026 to Sep 2026
    • Completion pushed from Dec 2026 to Aug 2027
  4. Start date: Jan 2026 to Apr 2026 Primary completion date: Jun 2026 to Sep 2026 · Completion date: Sep 2026 to Dec 2026 · Site contact updated · 1 morev4 Show 4 more changesShow less
    • Primary completion date: Jun 2026 to Sep 2026
    • Completion date: Sep 2026 to Dec 2026
    • Site contact updated
    • Eligibility criteria shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  5. Start date: Aug 2025 to Jan 2026 Primary completion date: Dec 2025 to Jun 2026 · Completion date: Feb 2026 to Sep 2026v3 Show 2 more changesShow less
    • Primary completion date: Dec 2025 to Jun 2026
    • Completion date: Feb 2026 to Sep 2026
  6. Eligibility criteria shortened, about 26 wordsv2 See this version in full on ClinicalTrials.gov ↗
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to assess the efficacy and safety of emodepside compared to mebendazole in adults and adolescents infected with T. trichiura, either as single infection or co-infections with hookworm and/or A. lumbricoides.
Trial Details
NCT Number NCT06800248
Lead Sponsor Swiss Tropical & Public Health Institute
Collaborators: Bayer, University of the Philippines, Coefficient Giving (Formerly Open Philanthropy)
Conditions Trichuris Trichiura; Infection, Hookworm Infection, Ascaris Lumbricoides Infection
Enrollment 315 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov